The frequency of hepatotoxicity and myelotoxicity in leukemic children with different high doses of methotrexate

Background and objectives: Methotrexate (MTX) is a chemotherapeutic agent that functions as a folic acid antagonist. The frequency of high dose methotrexate (HDMTX)-associated toxicity is variable. In this study, we investigated the frequency of myelotoxicity and hepatotoxicity 7 days after HDMTX in...

Full description

Bibliographic Details
Main Authors: Zeynep Canan Özdemir, Ayşe Bozkurt Turhan, Yeter Düzenli Kar, Özcan Bör
Format: Article
Language:English
Published: Elsevier 2016-12-01
Series:International Journal of Pediatrics and Adolescent Medicine
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2352646716300588